May 08, 2019 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2019 Earnings Conference Call May 8, 2019, 08:30 AM ET Company Participants David Price - CFO Nancy Lurker - President and CEO Conference Call Participa
May 01, 2019 - EyePoint Pharmaceuticals (EYPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mar 14, 2019 - EYPT earnings call for the period ending December 31, 2018.
Mar 14, 2019 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2019 Earnings Conference Call March 14, 2019 08:30 AM ET Company Participants Nancy Lurker - President and Chief Executive Officer David Price - Chief F
Mar 14, 2019 - EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of 14.29% and 272.82%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Nov 29, 2018 - Investors need to pay close attention to EyePoint Pharmaceuticals (EYPT) stock based on the movements in the options market lately.
Nov 06, 2018 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2019 Results Conference Call November 06, 2018 08:00 AM ET Executives Nancy Lurker - President and Chief Executive Officer David Price - Chief Financial
Oct 17, 2018 - EyePoint (EYPT) gains an FDA approval for its eye therapy Yutiq to help cure chronic non-infectious uveitis affecting the posterior segment of the eye.
Oct 01, 2018 - Investors need to pay close attention to EyePoint Pharmaceuticals (EYPT) stock based on the movements in the options market lately.
Sep 12, 2018 - EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2018 Earnings Conference Call September 12, 2018 08:30 AM ET Executives David Price - CFO Nancy Lurker - President and CEO Leonard Ross - VP, Finance an